[smt88]

That's a big (and incorrect) assumption about my mentality. This isn't about trying to claim someone is a victim, least of all myself!

It is, however, a cautionary tale about how inefficient and risky nepotism is. It didn't hurt me at all, but it hurt the investors who failed to examine Theranos' merit.

It's also separately interesting because SV's meritocracy is a fairly prevalent myth, and it's what people believe (or believed) was special about SV in the first place.